NCT06666972 is a clinical trial of PCR MTB/NTM in Tuberculosis Diagnosis, sponsored by Assiut University.

Who is sponsoring NCT06666972?

NCT06666972 is sponsored by Assiut University.

What drugs are being tested in NCT06666972?

Interventions in NCT06666972: PCR MTB/NTM.

What condition does NCT06666972 study?

NCT06666972 studies Tuberculosis Diagnosis.

Is NCT06666972 still recruiting?

NCT06666972 is currently not yet recruiting. Last updated 5 November 2024.

Last reviewed 2024-11-05 · How we verify

NCT06666972

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of Different Diagnostic Methods of Tuberculosis in Assiut University Hospitals

Not yet recruiting Last updated 5 November 2024

What this trial tests

trial testing PCR MTB/NTM in Tuberculosis Diagnosis in 166 participants. Not yet recruiting.

Timeline

1 January 2025

Primary endpoint
30 December 2025

30 September 2026

Quick facts

Lead sponsor	Assiut University
Status	Not yet recruiting
Study type	OBSERVATIONAL
Enrollment	166
Start date	1 January 2025
Primary completion	30 December 2025
Estimated completion	30 September 2026

Drugs / interventions tested

PCR MTB/NTM

Conditions studied

Tuberculosis Diagnosis — all drugs for Tuberculosis Diagnosis →

Sponsor

Assiut University

Who can join

Eligibility, any sex, with Tuberculosis Diagnosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

* Detection of sensitivity and specificity of microscopic examination and Molecular studies using polymerase chain reaction (PCR) Mycobacterium tuberculosis (MTB)/ non tuberculous mycobacterium (NTM) MDR-TB compared to culture which is the gold standard technique in the diagnosis of TB to reach the most reliable one for better health care service. * Assess the prevalence of tuberculosis cases among clinically suspected cases admitted to the hospital throughout the selected study period.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06666972 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 5 November 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06666972.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing